One such compound, NuBCP-9, a highly promising anticancer peptide, specifically induces apoptosis in cancer cells by exposing the BH3 domain of Bcl-2, thereby inhibiting the survival function of Bcl-XL [52]. The gene discussed is BCL2; the disease is cancer.